Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease

Generalized Gradient Approximation Made Simple

Perdew, J. P., Burke, K., & Ernzerhof, M. (1996) · Physical Review Letters · doi:10.1103/physrevlett.77.3865 · Cited by 215,824 · see citing works

Efficient iterative schemes for <i>ab initio</i> total-energy calculations using a plane-wave basis set

Kresse, G., & Furthmüller, J. (1996) · Physical Review B · doi:10.1103/physrevb.54.11169 · Cited by 123,652 · see citing works

Projector augmented-wave method

Blöchl, P. E. (1994) · Physical Review B · doi:10.1103/physrevb.50.17953 · Cited by 92,732 · see citing works

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,745 · see citing works

Neurodegenerative diseases and oxidative stress

Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · see citing works

The golden age: gold nanoparticles for biomedicine

Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El‐Sayed, M. A. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15237h · Cited by 3,572 · see citing works

Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Comparison of CONTIN, SELCON, and CDSSTR Methods with an Expanded Reference Set

Sreerama, N., & Woody, R. W. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4880 · Cited by 2,997 · see citing works

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · see citing works

The Amyloid State of Proteins in Human Diseases

Eisenberg, D. S., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,732 · see citing works

Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils

Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural &amp; Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111 · see citing works

Nucleation of protein fibrillation by nanoparticles

Linse, S. S., Cabaleiro-Lago, C., Xue, W., Lynch, I., Lindman, S., Thulin, E., Radford, S. E., & Dawson, K. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701250104 · Cited by 887 · see citing works

β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy

Soto, C. A., Sigurdsson, E. M., Morelli, L., Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 874 · see citing works

Alzheimer's disease: experimental models and reality

Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810 · see citing works

A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain

Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808 · see citing works

Clinical trials and late‐stage drug development for <scp>A</scp>lzheimer's disease: an appraisal from 1984 to 2014

Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12191 · Cited by 651 · see citing works

Amyloid precursor protein processing and Aβ 42 deposition in a transgenic mouse model of Alzheimer disease

Johnson‐Wood, K., Lee, M., Motter, R. N., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M. N., Tan, H. T., Games, D., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1550 · Cited by 634 · see citing works

Alzheimer's Disease: From Pathology to Therapeutic Approaches

Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626 · see citing works

Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight

Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595 · see citing works

World Alzheimer Report 2018: The state of the art of dementia research: New frontiers

Patterson, C. (2018) · Cited by 586 · see citing works

Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles

Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Lindman, S., Minogue, A. M., Thulin, E., Walsh, D. M., Dawson, K. A., & Linse, S. S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8041806 · Cited by 547 · see citing works

Biological metals and metal-targeting compounds in major neurodegenerative diseases

Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497 · see citing works

Glutathione metabolism and Parkinson's disease

Smeyne, M., & Smeyne, R. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.001 · Cited by 436 · see citing works

The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types

Schlinkert, P., Casals, E., Boyles, M. S. P., Tischler, U., Hornig, E., Tran, N. T. T., Zhao, J., Himly, M., Riediker, M., Oostingh, G. J., et al. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-014-0062-4 · Cited by 382 · see citing works

Elevation of Glutathione as a Therapeutic Strategy in Alzheimer Disease

Pocernich, C., & Butterfield, D. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2011.10.003 · Cited by 333 · see citing works

Negatively Charged Gold Nanoparticles Inhibit Alzheimer's Amyloid‐β Fibrillization, Induce Fibril Dissociation, and Mitigate Neurotoxicity

Liao, Y., Chang, Y., Yoshiike, Y., Chang, Y. C., & Chen, Y. (2012) · Small · doi:10.1002/smll.201201068 · Cited by 324 · see citing works

Inhibition of protein aggregation and amyloid formation by small molecules

Doig, A. J., & Derreumaux, P. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.12.004 · Cited by 295 · see citing works

The Ratio of Monomeric to Aggregated Forms of Aβ40 and Aβ42 Is an Important Determinant of Amyloid-β Aggregation, Fibrillogenesis, and Toxicity

Jan, A., Gokce, O., Luthi-Carter, R., & Lashuel, H. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803159200 · Cited by 291 · see citing works

Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer’s disease

Gao, N., Sun, H., Dong, K., Ren, J., Duan, T., Xu, C., & Qu, X. (2014) · Nature Communications · doi:10.1038/ncomms4422 · Cited by 263 · see citing works

The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model

Shilo, M., Sharon-Buller, A., Baranes, K., Motiei, M., Lellouche, J., & Popovtzer, R. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0075-7 · Cited by 236 · see citing works

Physicochemical Characteristics of Protein–NP Bioconjugates: The Role of Particle Curvature and Solution Conditions on Human Serum Albumin Conformation and Fibrillogenesis Inhibition

Goy‐López, S., Juárez, J., Alatorre‐Meda, M., Casals, E., Puntes, V., Taboada, P., & Mosquera, V. (2012) · Langmuir · doi:10.1021/la300402w · Cited by 212 · see citing works

Epigallocatechin-3-gallate (EGCG)-Stabilized Selenium Nanoparticles Coated with Tet-1 Peptide To Reduce Amyloid-β Aggregation and Cytotoxicity

Zhang, J., Zhou, X., Yu, Q., Yang, L., Sun, D., Zhou, Y., & Liu, J. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am501341u · Cited by 199 · see citing works

The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation

Gao, G., Zhang, M., Gong, D., Chen, R., Hu, X., & Sun, T. (2017) · Nanoscale · doi:10.1039/c7nr00699c · Cited by 164 · see citing works

Neuropilin-1-Targeted Gold Nanoparticles Enhance Therapeutic Efficacy of Platinum(IV) Drug for Prostate Cancer Treatment

Kumar, A., Huo, S., Zhang, X., Liu, J., Tan, A., Li, S., Jin, S., Xue, X., Zhao, Y., Ji, T., et al. (2014) · ACS Nano · doi:10.1021/nn500152u · Cited by 162 · see citing works

Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers

Geldenhuys, W. J., Mbimba, T., Bui, T., Harrison, K. A., & Sutariya, V. B. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.589435 · Cited by 144 · see citing works

Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB)

Sela, H., Cohen, H., Elia, P., Zach, R., Karpas, Z., & Yehuda Zeiri, B. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0133-1 · Cited by 129 · see citing works

Chiral Effect at Protein/Graphene Interface: A Bioinspired Perspective To Understand Amyloid Formation

Qing, G., Zhao, S., Xiong, Y., Lv, Z., Jiang, F., Liu, Y., Chen, H., Zhang, M., & Sun, T. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5049626 · Cited by 119 · see citing works

How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?

Kim, Y., Park, J., Lee, H., & Nam, J. (2016) · Scientific Reports · doi:10.1038/srep19548 · Cited by 118 · see citing works

A super highly sensitive glucose biosensor based on Au nanoparticles–AgCl@polyaniline hybrid material

Yan, W., Feng, X., Chen, X., Hou, W., & Zhu, J. (2007) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2007.09.002 · Cited by 111 · see citing works

Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β‐Protein Aggregation and Cytotoxicity

Xiong, N., Yan-Jiao, Z. H. A. O., Dong, X., Zheng, J., & Sun, Y. P. (2017) · Small · doi:10.1002/smll.201601666 · Cited by 106 · see citing works

Engineered Polymer Nanoparticles Containing Hydrophobic Dipeptide for Inhibition of Amyloid-β Fibrillation

Skaat, H., Chen, R., Grinberg, I., & Margel, S. (2012) · Biomacromolecules · doi:10.1021/bm3011177 · Cited by 104 · see citing works

A Condensation-Ordering Mechanism in Nanoparticle-Catalyzed Peptide Aggregation

Auer, S., Trovato, A., & Vendruscolo, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000458 · Cited by 102 · see citing works

Amyloid-Derived Peptide Forms Self-Assembled Monolayers on Gold Nanoparticle with a Curvature-Dependent β-Sheet Structure

Shaw, C. P., Middleton, D. A., Volk, M., & Lévy, R. (2012) · ACS Nano · doi:10.1021/nn204214x · Cited by 90 · see citing works

X-ray Crystallographic Structures of Trimers and Higher-Order Oligomeric Assemblies of a Peptide Derived from Aβ17–36

Spencer, R. K., Li, H., & Nowick, J. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5017409 · Cited by 86 · see citing works

Stereochemistry and amyloid inhibition: Asymmetric triplex metallohelices enantioselectively bind to Aβ peptide

Guan, Y., Du, Z., Gao, N., Cao, Y., Wang, X., Scott, P., Song, H. L., Ren, J., & Qu, X. (2018) · Science Advances · doi:10.1126/sciadv.aao6718 · Cited by 81 · see citing works

Inhibiting amyloid-β cytotoxicity through its interaction with the cell surface receptor LilrB2 by structure-based design

Cao, Q., Shin, W. S., Chan, H., Vuong, C. K., Dubois, B., Li, B., Murray, K. A., Sawaya, M. R., Feigon, J., Black, D. L., et al. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0147-z · Cited by 75 · see citing works

Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease

Chang, K. L., Pee, H. N., Yang, S., & Ho, P. C. (2015) · Scientific Reports · doi:10.1038/srep09000 · Cited by 65 · see citing works

Erratum: How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?

Kim, Y., Park, J., Lee, H., & Nam, J. (2016) · Scientific Reports · doi:10.1038/srep22173 · Cited by 58 · see citing works

Characterizing the Effect of Multivalent Conjugates Composed of Aβ-Specific Ligands and Metal Nanoparticles on Neurotoxic Fibrillar Aggregation

Streich, C., Akkari, L., Decker, C., Bormann, J., Rehbock, C., Müller‐Schiffmann, A., Niemeyer, F. C., Nagel‐Steger, L., Willbold, D., Saccà, B., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02627 · Cited by 52 · see citing works

One pot synthesis of monodispersed L-glutathione stabilized gold nanoparticles for the detection of Pb2+ ions

Mao, X., Li, Z., & Tang, Z. (2010) · Frontiers of Materials Science · doi:10.1007/s11706-011-0118-4 · Cited by 43 · see citing works

Physical Gelation of Polypeptide–Polyelectrolyte–Polypeptide (ABA) Copolymer in Solution

Zhang, R., Duan, X., Shi, T., Li, H., An, L., & Huang, Q. (2012) · Macromolecules · doi:10.1021/ma300663p · Cited by 9 · see citing works

The blood–brain barrier: Structure, regulation and drug delivery

Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906 · see citing works

Rational Design of Multicolor‐Emitting Chiral Carbonized Polymer Dots for Full‐Color and White Circularly Polarized Luminescence

Ru, Y., Sui, L., Song, H., Liu, X., Tang, Z., Zang, S., Yang, B. J., & Lu, S. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202103336 · Cited by 290 · see citing works

Chiral carbon dots: synthesis, optical properties, and emerging applications

Döring, A., Ushakova, E. V., & Rogach, A. L. (2022) · Light Science & Applications · doi:10.1038/s41377-022-00764-1 · Cited by 295 · see citing works

Self-assembled inorganic chiral superstructures

Lv, J., Gao, X., Han, B. Q., Zhu, Y., Hou, K., & Tang, Z. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00350-w · Cited by 269 · see citing works

In situ analysis of nanoparticle soft corona and dynamic evolution

Baimanov, D., Wang, J., Zhang, J., Liu, K., Cong, Y., Shi, X., Zhang, X., Li, Y., Li, X., Qiao, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33044-y · Cited by 211 · see citing works

Precision-engineered metal and metal-oxide nanoparticles for biomedical imaging and healthcare applications

Truong, T. T., Mondal, S. A., Doan, V. H. M., Tak, S., Choi, J., Oh, H., Nguyen, T. D., Misra, M., Lee, B., & Oh, J. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103263 · Cited by 190 · see citing works

Circularly Polarized Fluorescence Resonance Energy Transfer (C‐FRET) for Efficient Chirality Transmission within an Intermolecular System

Wu, Y., Yan, C., Li, X., Li, Y., Yu, Z., Wu, X., Zheng, Z., Liu, G., Guo, Z., Tian, H., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202109054 · Cited by 185 · see citing works

Chiral Phosphine–Copper Iodide Hybrid Cluster Assemblies for Circularly Polarized Luminescence

Wang, J., Zhou, H., Yang, J., Feng, L., Yao, J., Song, K., Zhou, M., Jin, S., Zhang, G., & Yao, H. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05476 · Cited by 179 · see citing works

Ultrasmall Coinage Metal Nanoclusters as Promising Theranostic Probes for Biomedical Applications

Ge, Y., Wang, Z., Du, F., Jiang, F., Yuan, X. F., & Ying, J. Y. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c02880 · Cited by 163 · see citing works

Chiral Seeded Growth of Gold Nanorods Into Fourfold Twisted Nanoparticles with Plasmonic Optical Activity

Ni, B., Mychinko, M., Gómez‐Graña, S., Morales‐Vidal, J., Obelleiro‐Liz, M., Heyvaert, W., Vila‐Liarte, D., Zhuo, X., Albrecht, W., Zheng, G., et al. (2022) · Advanced Materials · doi:10.1002/adma.202208299 · Cited by 161 · see citing works

Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers

Singh, A. V., Chandrasekar, V., Janapareddy, P., Mathews, D. E., Laux, P., Luch, A., Yang, Y., Canibaño, B., Balakrishnan, S., Abinahed, J. A., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00087 · Cited by 159 · see citing works

NIR‐II Hydrogen‐Bonded Organic Frameworks (HOFs) Used for Target‐Specific Amyloid‐β Photooxygenation in an Alzheimer's Disease Model

Zhang, H., Yu, D., Liu, S., Liu, C., Liu, Z., Ren, J., & Qu, X. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202109068 · Cited by 135 · see citing works

Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers

Gao, X. J., Ciura, K., Ma, Y., Mikołajczyk, A., Jagiełło, K., Wan, Y., Gao, Y., Zheng, J., Zhong, S., Puzyn, T., et al. (2024) · Advanced Materials · doi:10.1002/adma.202407793 · Cited by 125 · see citing works

Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems

Poudel, P., & Park, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040835 · Cited by 124 · see citing works

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases

Jagaran, K., & Singh, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169082 · Cited by 114 · see citing works

Chiral nanoparticle-remodeled gut microbiota alleviates neurodegeneration via the gut–brain axis

Guo, X. L., Li, C., Zhang, J., Sun, M., Xu, J., Xu, C., Kuang, H., & Xu, L. (2023) · Nature Aging · doi:10.1038/s43587-023-00516-9 · Cited by 110 · see citing works

The Development of Chiral Nanoparticles to Target NK Cells and CD8+ T Cells for Cancer Immunotherapy

Wang, W., Zhao, J., Hao, C., Hu, S., Chen, C., Cao, Y., Xu, Z., Guo, J., Xu, L., Sun, M., et al. (2022) · Advanced Materials · doi:10.1002/adma.202109354 · Cited by 103 · see citing works

Cu2+‐Chelatable and ROS‐Scavenging MXenzyme as NIR‐II‐Triggered Blood–Brain Barrier‐Crossing Nanocatalyst against Alzheimer's Disease

Du, C., Feng, W., Dai, X., Wang, J., Geng, D., Li, X., Chen, Y., & Zhang, J. (2022) · Small · doi:10.1002/smll.202203031 · Cited by 103 · see citing works

Near‐Infrared Aggregation‐Induced Emission Luminogens for In Vivo Theranostics of Alzheimer's Disease

Zhang, T., Chen, X., Yuan, C., Pang, X., Shangguan, P., Liu, Y., Han, L., Sun, J., Lam, J. W. Y., Liu, Y., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202211550 · Cited by 102 · see citing works

Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection

Chiang, M., Yang, Y., Nicol, C. J. B., & Wang, C.-J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042360 · Cited by 106 · see citing works

Reversing the Chirality of Surface Ligands Can Improve the Biosafety and Pharmacokinetics of Cationic Gold Nanoclusters

Tang, H., Li, Q., Yan, W., & Jiang, X. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101609 · Cited by 95 · see citing works

Emerging trends in chiral inorganic nanomaterials for enantioselective catalysis

Li, S., Xu, X., Xu, L., Lin, H., Kuang, H., & Xu, C. (2024) · Nature Communications · doi:10.1038/s41467-024-47657-y · Cited by 93 · see citing works

A review of metallic nanoparticles: present issues and prospects focused on the preparation methods, characterization techniques, and their theranostic applications

Shahalaei, M., Azad, A. K., Sulaiman, W. M. A. W., Derakhshani, A., Mofakham, E. B., Mallandrich, M., Kumarasamy, V., & Subramaniyan, V. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1398979 · Cited by 93 · see citing works

Trilobatin rescues cognitive impairment of Alzheimer’s disease by targeting HMGB1 through mediating SIRT3/SOD2 signaling pathway

Gao, J.-M., Zhang, X., Shu, G., Chen, N., Zhang, J., Xu, F., Li, F., Liu, Y., Wei, Y., He, Y., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00888-5 · Cited by 95 · see citing works

Ultrasmall Magneto-chiral Cobalt Hydroxide Nanoparticles Enable Dynamic Detection of Reactive Oxygen Species in Vivo

Li, C., Li, S., Zhao, J., Sun, M., Wang, W., Lu, M., Qu, A., Hao, C., Chen, C., Xu, C., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c09986 · Cited by 87 · see citing works

Site-selective proteolytic cleavage of plant viruses by photoactive chiral nanoparticles

Gao, R., Xu, L., Sun, M., Xu, M., Hao, C., Guo, X. L., Colombari, F. M., Zheng, X., Král, P., de Moura, A. F., et al. (2022) · Nature Catalysis · doi:10.1038/s41929-022-00823-1 · Cited by 86 · see citing works

Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends

Zeng, H., Qi, Y., Zhang, Z., Liu, C., Peng, W., & Zhang, Y. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.014 · Cited by 82 · see citing works

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease

Khan, N. H., Mir, M., Ngowi, E. E., Zafar, U., Khakwani, M. M. A. K., Khattak, S., Zhai, Y., Jiang, E., Zheng, M., Duan, S., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.630055 · Cited by 82 · see citing works

Cu 2+ -Dominated Chirality Transfer from Chiral Molecules to Concave Chiral Au Nanoparticles

Wan, J., Sun, L., Sun, X., Liu, C., Yang, G., Zhang, B., Tao, Y., Yang, Y., & Zhang, Q. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c00322 · Cited by 84 · see citing works

Chirality communications between inorganic and organic compounds

Ni, B., & Cölfen, H. (2021) · SmartMat · doi:10.1002/smm2.1021 · Cited by 81 · see citing works

Biomaterials in treatment of Alzheimer's disease

Agrawal, M., Prathyusha, E., Ahmed, H., Dubey, S. K., Kesharwani, P., Singhvi, G., Naidu, V. G. M., & Alexander, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105008 · Cited by 79 · see citing works

The roles of gold nanoparticles in the detection of amyloid-β peptide for Alzheimer's disease

Zhao, J., Xu, N., Yang, X., Ling, G., & Zhang, P. (2022) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2021.100579 · Cited by 77 · see citing works

Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease

Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 76 · see citing works

Synthesis of carbon quantum dots for application of alleviating amyloid-β mediated neurotoxicity

Li, H., Zhang, Y., Ding, J., Wu, T. H., Cai, S., Zhang, W., Cai, R., Chen, C., & Yang, R. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112373 · Cited by 72 · see citing works

Chirality at nanoscale for bioscience

Sun, M., Wang, X., Guo, X. L., Xu, L., Kuang, H., & Xu, C. (2022) · Chemical Science · doi:10.1039/d1sc06378b · Cited by 72 · see citing works

Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation

Jia, W., Wu, Y., Xie, Y., Yu, M., & Chen, Y. (2025) · Advanced Materials · doi:10.1002/adma.202413603 · Cited by 74 · see citing works

Chiral Nanoparticles Force Neural Stem Cell Differentiation to Alleviate Alzheimer's Disease

Shi, B., Zhao, J., Xu, Z., Chen, C., Xu, L., Xu, C., Sun, M., & Kuang, H. (2022) · Advanced Science · doi:10.1002/advs.202202475 · Cited by 70 · see citing works

Chiral NIR-II fluorescent Ag2S quantum dots with stereospecific biological interactions and tumor accumulation behaviors

Qu, S., Jia, Q., Li, Z., Wang, Z., & Shang, L. (2022) · 中国科学通报：英文版 · doi:10.1016/j.scib.2022.05.001 · Cited by 69 · see citing works

Advancements in the Blood–Brain Barrier Penetrating Nanoplatforms for Brain Related Disease Diagnostics and Therapeutic Applications

Thangudu, S., Cheng, F., & Su, C. (2020) · Polymers · doi:10.3390/polym12123055 · Cited by 65 · see citing works

Rational Design of Multicolor‐Emitting Chiral Carbonized Polymer Dots for Full‐Color and White Circularly Polarized Luminescence

Ru, Y., Sui, L., Song, H., Liu, X., Tang, Z., Zang, S., Yang, B., & Lu, S. (2021) · Angewandte Chemie · doi:10.1002/ange.202103336 · Cited by 64 · see citing works

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective

Nayab, D. E., Din, F. U., Ali, H., Kausar, W. A., Urooj, S., Zafar, M., Khan, I., Shabbir, K., & Khan, G. M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02250-1 · Cited by 68 · see citing works

Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases

Khalil, A., Barras, A., Boukherroub, R., Tseng, C., Devos, D., Burnouf, T. P. R., Neuhaus, W., & Szunerits, S. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00306j · Cited by 62 · see citing works

Shining light on chiral inorganic nanomaterials for biological issues

Shao, Y., Yang, G., Lin, J.-Y., Fan, X., Guo, Y., Zhu, W., Cai, Y., Huang, H., Hu, D., Pang, W., et al. (2021) · Theranostics · doi:10.7150/thno.64511 · Cited by 62 · see citing works

Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art

Ullah, S. N. M. N., Afzal, O., Altamimi, A. S. A., Ather, H., Sultana, S., Almalki, W. H., Bharti, P., Sahoo, A., Dwivedi, K., Khan, G., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061752 · Cited by 61 · see citing works

Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer’s Patients

Abbas, M. (2021) · Polymers · doi:10.3390/polym13071051 · Cited by 47 · see citing works

Amyloid-β-targeting immunotherapies for Alzheimer's disease

Jin, Y., Du, Q., Song, M., Kang, R., Zhou, J., Zhang, H., & Ding, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.012 · Cited by 57 · see citing works

Chiral inorganic nanomaterials for biomedical applications

Cho, N. H., Kim, H., Kim, J. W., Lim, Y., Kim, R. M., Lee, Y. H., & Nam, K. T. (2024) · Chem · doi:10.1016/j.chempr.2023.12.016 · Cited by 56 · see citing works

Chiral Gold Nanostructure Monolayers as SERS Substrates for Ultrasensitive Detection of Enantiomer Biomarkers of Alzheimer's Disease

Hao, C., Meng, D., Shi, W., Xu, C., Wang, Q., & Kuang, H. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202502115 · Cited by 56 · see citing works

Borneol-driven meningeal lymphatic drainage clears amyloid-β peptide to attenuate Alzheimer-like phenotype in mice

Wu, Y., Zhang, T., Li, X., Wei, Y., Li, X., Wang, S., Liu, J., Li, D., Wang, S., & Ye, T. (2022) · Theranostics · doi:10.7150/thno.76133 · Cited by 55 · see citing works

Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment

Jang, Y.-J., Kang, S.-J., Park, H. S., Lee, D., Kim, J. H., Kim, J.-E., Kim, D., Chung, C., Yoon, J., & Bhang, S. H. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03109-3 · Cited by 62 · see citing works

Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer’s β-Amyloid

Wang, W., Liu, M., Gao, W., Sun, Y., & Dong, X. (2021) · ACS Applied Materials &amp; Interfaces · doi:10.1021/acsami.1c17267 · Cited by 53 · see citing works

Chiral‐Selective Antigen‐Presentation by Supramolecular Chiral Polymer Micelles

Jiang, H., Liu, R., Wang, L., Wang, X., Zhang, M., Lin, S., Cao, Z., Wu, F., Liu, Y., & Liu, J. (2022) · Advanced Materials · doi:10.1002/adma.202208157 · Cited by 51 · see citing works

Site‐Selective Chiral Growth of Anisotropic Au Triangular Nanoplates for Tuning the Optical Chirality

Tao, Y., Sun, L., Liu, C., Yang, G., Sun, X., & Zhang, Q. (2023) · Small · doi:10.1002/smll.202301218 · Cited by 51 · see citing works

Inorganic nano-drug delivery systems for crossing the blood–brain barrier: Advances and challenges

Tan, Q., Zhao, S., Xu, T., Wang, Q. L., Zhang, M., Yan, L., Chen, X., & Lan, M. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215344 · Cited by 51 · see citing works

Metal Nanoparticles in Alzheimer’s Disease

Behera, A., Sa, N., Pradhan, S. P., Swain, S., & Sahu, P. K. (2023) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-220112 · Cited by 50 · see citing works

Photoinduced elimination of senescent microglia cells in vivo by chiral gold nanoparticles

Xu, Z., Qu, A., Zhang, H., Wang, W., Hao, C., Lu, M., Shi, B., Xu, L., Sun, M., Xu, C., et al. (2022) · Chemical Science · doi:10.1039/d2sc01662a · Cited by 49 · see citing works

Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis

Li, L., He, R., Yan, H., Leng, Z., Zhu, S., & Gu, Z. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101654 · Cited by 48 · see citing works

Chiral Nanosilica Drug Delivery Systems Stereoselectively Interacted with the Intestinal Mucosa to Improve the Oral Adsorption of Insoluble Drugs

Chen, X., Cheng, Y., Pan, Q., Wu, L., Hao, X., Bao, Z., Li, X., Yang, M., Luo, Q., & Li, H. (2023) · ACS Nano · doi:10.1021/acsnano.2c10818 · Cited by 49 · see citing works

Facet‐Dependent Biodegradable Mn3O4 Nanoparticles for Ameliorating Parkinson's Disease

Xu, Z., Qu, A., Wang, W., Lu, M., Shi, B., Chen, C., Hao, C., Xu, L., Sun, M., Xu, C., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101316 · Cited by 49 · see citing works

Chiral inorganic nanomaterials for biological applications

Wang, F., Yue, X., Ding, Q., Lin, H., Xu, C., & Li, S. (2023) · Nanoscale · doi:10.1039/d2nr05689e · Cited by 47 · see citing works

Advances in Enantiomer-Dependent Nanotherapeutics

Wang, Y., & Tay, A. K. P. (2023) · ACS Nano · doi:10.1021/acsnano.3c02798 · Cited by 47 · see citing works

Large Amino Acid Mimicking Selenium-Doped Carbon Quantum Dots for Multi-Target Therapy of Alzheimer’s Disease

Zhou, X. C., Hu, S., Wang, S., Pang, Y., Lin, Y., & Li, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.778613 · Cited by 46 · see citing works

Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials

Conklin, B., Conley, B. M., Hou, Y., Chen, M., & Lee, K.-B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114636 · Cited by 45 · see citing works

Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments

Scarpa, E., Cascione, M., Griego, A., Pellegrino, P., Moschetti, G., & Matteis, V. D. (2023) · Ibrain · doi:10.1002/ibra.12126 · Cited by 45 · see citing works

Tuning the Geometry and Optical Chirality of Pentatwinned Au Nanoparticles with 5-Fold Rotational Symmetry

Sun, X., Sun, L., Lin, L., Guo, S., Yang, Y., Zhang, B., Liu, C., Tao, Y., & Zhang, Q. (2024) · ACS Nano · doi:10.1021/acsnano.3c12637 · Cited by 45 · see citing works

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects

Chopra, H., Bibi, S., Singh, I., Kamal, M. A., Islam, F., Alhumaydhi, F. A., Emran, T. B., & Cavalu, S. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879114 · Cited by 47 · see citing works

Gold Nanoparticle-Based Therapy for Muscle Inflammation and Oxidative Stress

Pinho, R. A., Haupenthal, D. P., Fauser, P. E., Thirupathi, A., & Silveira, P. C. L. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s327292 · Cited by 27 · see citing works

Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases

Mistretta, M., Farini, A., Torrente, Y., & Villa, C. (2023) · Brain · doi:10.1093/brain/awad014 · Cited by 43 · see citing works

Emerging nanotechnology for Alzheimer's disease: From detection to treatment

Song, N., Sun, S., Chen, K., Wang, Y., Wang, H., Meng, J., Guo, M., Zhang, X.-D., & Zhang, R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.004 · Cited by 44 · see citing works

Chirality Effects in Peptide Assembly Structures

Zheng, Y., Mao, K., Chen, S., & Zhu, H. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.703004 · Cited by 44 · see citing works

Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective

Puranik, N., Yadav, D., & Song, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814044 · Cited by 44 · see citing works

A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies

Wasielewska, J. M., Chaves, J. C. S., Johnston, R. L., Milton, L. A., Hernández, D., Chen, L., Song, J. H., Lee, W., Leinenga, G., Nisbet, R. M., et al. (2022) · Theranostics · doi:10.7150/thno.72685 · Cited by 40 · see citing works

GSH-AuNP anti-oxidative stress, ER stress and mitochondrial dysfunction in amyloid-beta peptide-treated human neural stem cells

Chiang, M., & Nicol, C. J. B. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.05.025 · Cited by 41 · see citing works

Medical importance and pharmacokinetics of gold nanoparticles in the human body

Singh, P., Joshi, A. S., Singh, H., & Mijakovic̀, I. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02418-3 · Cited by 41 · see citing works

Biological applications of chiral inorganic nanomaterials

Fan, Y., Ouyang, S., Zhou, D., Wei, J., & Liao, L. (2022) · Chirality · doi:10.1002/chir.23428 · Cited by 40 · see citing works

Recent progress of nanomedicine in the treatment of Alzheimer’s disease

Hu, L., Tao, Y., Jiang, Y., & Qin, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1228679 · Cited by 40 · see citing works

Neuromodulation by nanozymes and ultrasound during Alzheimer’s disease management

Karthika, V., Sridharan, B., Nam, J. W., Kim, D., & Lim, H. G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02406-7 · Cited by 38 · see citing works

Natural stereoisomeric flavonoids exhibit different disruptive effects and the mechanism of action on Aβ 42 protofibril

Zhan, C., Lao, Z., Tang, Y., Qiao, Q., & Wei, G. (2021) · Chemical Communications · doi:10.1039/d1cc00404b · Cited by 37 · see citing works

Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer’s Diseases

Yang, H., Tan, H., Wen, H., Xin, P., Liu, Y., Deng, Z., Xu, Y., Gao, F., Zhang, L., Ye, Z., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c11966 · Cited by 37 · see citing works

Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system

Luo, Q., Yang, J., Yang, M., Wang, Y., Liu, Y., Liu, J., Kalvakolanu, D. V., Cong, X., Zhang, J., Zhang, L., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101457 · Cited by 39 · see citing works

Advanced Nanomedicines for Treating Refractory Inflammation-Related Diseases

Wang, X., Song, X., Feng, W., Chang, M., Yang, J., & Chen, Y. (2025) · Nano-Micro Letters · doi:10.1007/s40820-025-01829-7 · Cited by 41 · see citing works

Advance in the use of gold nanoparticles in the treatment of neurodegenerative diseases: new perspectives

Silveira, P. L., Muller, A. P., Machado‐de‐Ávila, R. A., & Silveira, P. C. L. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.313040 · Cited by 36 · see citing works

Chirality in peptide‐based materials: From chirality effects to potential applications

Chen, Z., Chi, Z., Sun, Y., & Lv, Z. (2021) · Chirality · doi:10.1002/chir.23344 · Cited by 35 · see citing works

Secreted endogenous macrosomes reduce Aβ burden and ameliorate Alzheimer’s disease

Wang, C., Yang, Y., Zhang, X., Shi, Z., Gao, H., Zhong, M., Fan, Y., Zhang, H., Liu, B., & Qing, G. (2023) · Science Advances · doi:10.1126/sciadv.ade0293 · Cited by 35 · see citing works

Acetylcholine esterase inhibitory activity of green synthesized nanosilver by naphthopyrones isolated from marine-derived Aspergillus niger

Abdelwahab, G. M., Mira, A., Cheng, Y., Abdelaziz, T. A., Lahloub, M., & Khalil, A. T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257071 · Cited by 35 · see citing works

Nanomaterials as Theranostic Agents for Cancer Therapy

Bauri, S., Tripathi, S., Choudhury, A. M., Mandal, S. S., Raj, H., & Maiti, P. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c04235 · Cited by 34 · see citing works

Expanding the Role of Chiral Drugs and Chiral Nanomaterials as a Potential Therapeutic Tool

Satapathy, S., Kumar, S., Kurmi, B. D., Gupta, G. D., & Patel, P. (2024) · Chirality · doi:10.1002/chir.23698 · Cited by 34 · see citing works

Chiral Engineered Biomaterials: New Frontiers in Cellular Fate Regulation for Regenerative Medicine

Wang, Y., Zhang, X., Xie, D., Chen, C., Huang, Z., & Li, Z. A. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202419610 · Cited by 35 · see citing works

Chiral Inorganic Nanomaterial‐Based Diagnosis and Treatments for Neurodegenerative Diseases

Dong, J., Xu, L., Qu, A., Hao, C., Sun, M., Xu, C., Hu, S., & Kuang, H. (2025) · Advanced Materials · doi:10.1002/adma.202418723 · Cited by 34 · see citing works

Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms

Cheng, G., Xie, A., Yan, Z., Zhu, X., Song, Y., & Chen, T. (2023) · Brain‐X · doi:10.1002/brx2.27 · Cited by 35 · see citing works

Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability

Song, Q., Li, J., Li, T., & Li, H. (2024) · Advanced Science · doi:10.1002/advs.202403473 · Cited by 34 · see citing works

Phosphorylation of covalent organic framework nanospheres for inhibition of amyloid-β peptide fibrillation

Yao, L., Zhou, Z., Wang, S., Zou, Q., Wang, H., Ma, L., Wang, S., & Zhang, X. (2022) · Chemical Science · doi:10.1039/d2sc00253a · Cited by 33 · see citing works

Chiral AuCu heterostructures with site-specific geometric control and tailored plasmonic chirality

Yang, G., Sun, L., Tao, Y., Cheng, Q., Sun, X., Liu, C., & Zhang, Q. (2023) · Science China Chemistry · doi:10.1007/s11426-023-1685-3 · Cited by 33 · see citing works

Role of Nanoparticle-Conjugates and Nanotheranostics in Abrogating Oxidative Stress and Ameliorating Neuroinflammation

Patel, T., Kevadiya, B. D., Bajwa, N., Singh, P. A., Zheng, H., Kirabo, A., Li, Y., & Patel, K. P. (2023) · Antioxidants · doi:10.3390/antiox12101877 · Cited by 32 · see citing works

Water-Induced Chiral Separation on a Au(111) Surface

Li, D., Sun, L., Ding, Y., Liu, M., Xie, L., Liu, Y., Shang, L., Wu, Y., Jiang, H., Chi, L., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c07842 · Cited by 32 · see citing works

Inhibiting protein aggregation with nanomaterials: The underlying mechanisms and impact factors

Wang, S., Zheng, J., Ma, L., Petersen, R. B., Xu, L., & Huang, K. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.130061 · Cited by 32 · see citing works

Exploiting mesoporous silica, silver and gold nanoparticles for neurodegenerative diseases treatment

Ribeiro, T. D. C., Sábio, R. M., Carvalho, G. C., Fonseca‐Santos, B., & Chorilli, M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121978 · Cited by 32 · see citing works

Interface Chirality: From Biological Effects to Biomedical Applications

Guo, L., Guo, Y., Wang, R., Feng, J., Shao, N., Zhou, X., & Zhou, Y. (2023) · Molecules · doi:10.3390/molecules28155629 · Cited by 31 · see citing works

Glutathione: a naturally occurring tripeptide for functional metal nanomaterials

Yang, Z., Lyu, J., Jing, Q., Wang, Y., Liu, Z., Yao, Q., Chen, T., Cao, Y., & Xie, J. (2025) · Chemical Science · doi:10.1039/d4sc08599j · Cited by 31 · see citing works

Bifunctional cysteine gold nanoclusters for β-amyloid fibril inhibition and fluorescence imaging: a distinctive approach to manage Alzheimer's disease

Resmi, A. N., Rekha, C. R., Dhushyandhun, M. E., Sarathkumar, E., Shenoy, S. J., Gulia, K. K., & Jayasree, R. S. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02802f · Cited by 16 · see citing works

Negatively Charged Gold Nanoparticles Inhibit Alzheimer's Amyloid‐β Fibrillization, Induce Fibril Dissociation, and Mitigate Neurotoxicity

Liao, Y., Chang, Y., Yoshiike, Y., Chang, Y. C., & Chen, Y. (2012) · Small · doi:10.1002/smll.201201068 · Cited by 324 · see citing works

Enantiomers of cysteine-modified SeNPs ( d / l SeNPs) as inhibitors of metal-induced Aβ aggregation in Alzheimer's disease

Zhou, X., Sun, J., Yin, T., Le, F., Yang, L., Liu, Y., & Liu, J. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00731c · Cited by 27 · see citing works

Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer's Disease Treatment?

Shaikh, S., Nazam, N., Rizvi, S. M. D., Hussain, T., Farhana, A., & Choi, I. (2020) · Current Protein and Peptide Science · doi:10.2174/1389203721666200226101930 · Cited by 8 · see citing works

A Novel Chiral Silver-Gold Alloy Nanoparticle System Functionalized with PEGylated Curcumin for Targeted Therapy of Alzheimer's Disease

Bakr, A. E. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.20426722